Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Update of ICT-107 Glioblastoma Clinical Trial: I C Great Potential In Dendritic Cell Therapies.

We originally posted the results from the ICT-107 Glioblastoma (GBM) Clinical Trial back in September 29, 2011 and marked it as a potential game changer in treatment of brain tumors. In short, ICT-107 is a vaccine based on dendritic cells, which... [Learn More...]

The post Update of ICT-107 Glioblastoma Clinical Trial: I C Great Potential In Dendritic Cell Therapies. appeared first on CTOAM.



This post first appeared on BLOG CATEGORIES - CTOAM, please read the originial post: here

Share the post

Update of ICT-107 Glioblastoma Clinical Trial: I C Great Potential In Dendritic Cell Therapies.

×

Subscribe to Blog Categories - Ctoam

Get updates delivered right to your inbox!

Thank you for your subscription

×